The UK hysteroscopy procedures market size is expected to reach USD 168.94 million by 2030, registering a CAGR of 7.41% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing adoption of technologically advanced devices and products for hysteroscopic procedures and the increasing competition among key players are the primary factors contributing to market growth. Companies operating in the industry, such as Medtronic, Hologic, Inc., and B. BRAUN MELSUNGEN AG, are developing novel devices and solutions that can be used in gynecological surgeries including hysteroscopy procedures.
The private and public organizations operating in the UK market are focusing on increasing awareness of gynecological conditions and treatment methods. They are conducting several workshops and events that can guide these procedures. For instance, in November 2021, the British Society for Gynecological Endoscopy (BSGE) conducted diagnostic and operative hysteroscopy workshops in Slough, England. The workshop aimed to develop hysteroscopy skills, and to become familiar with operative hysteroscopic equipment. It is appropriate for trainees in obstetrics and gynecology. Such efforts undertaken by various organizations to improve the knowledge and understanding of these procedures among healthcare professionals and the public are anticipated to drive market growth.
Furthermore, major companies are expanding their product portfolio and focusing on improving the accessibility of these products. For instance, in September 2021, Hologic, Inc. launched its expanded Omni suite to optimize operative and diagnostic hysteroscopy In Europe, including the UK. This suite includes an Omni 30° hysteroscope. In addition, in October 2023, Hologic adopted the HystAR hysteroscopy simulator from Inovus Medical, a supplier of training technologies headquartered in the UK. This simulator offers surgeons a scalable and reproducible environment for hysteroscopy skills training. Thus, the adoption of technologically advanced products from key players is anticipated to boost market growth over the forecast period.
Request a free sample copy or view report summary: UK Hysteroscopy Procedures Market Report
The CPT code 58558 segment dominated the market with a share of more than 33.3% in 2023 owing to the rising number of laparoscopic and hysteroscopic procedures
The CPT code 58562 segment is projected to grow at the fastest CAGR over the forecast period
Based on end-uses, the hospitals segment accounted for the largest revenue share of 45.38% in 2023. This dominance can be attributed to the rising investments from government bodies to increase the healthcare infrastructure and build hospitals
The ambulatory surgical centers (ASCs) segment is expected to register the fastest CAGR from 2024 to 2030
This growth is due to the several benefits offered by ASCs, such as reduced costs and waiting time
Grand View Research has segmented the UK hysteroscopy procedures market on the basis of CPT codes and end-use:
UK Hysteroscopy Procedures CPT Codes Outlook (Revenue, USD Million, 2018 - 2030)
CPT code 58555
CPT code 58558
CPT code 58562
CPT code 58340
CPT code 58563
CPT code 58565
CPT code 58353
CPT code 58561,74740 And More (Others)
UK Hysteroscopy Procedures End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Clinics
Ambulatory Surgery Centers
List of Key Players in the UK Hysteroscopy Procedures Market
Medtronic
Olympus Corp.
Stryker Corporation
B. Braun Melsungen AG
Johnson & Johnson (Ethicon, Inc)
Hologic, Inc.
Delmont Imaging
KARL STORZ SE & CO. KG
Richard Wolf GmbH
CooperCompanies
"The quality of research they have done for us has been excellent..."